Impact of Subcutaneous Abatacept in Rheumatoid Arthritis Assessing Inhibition of Structural Damage

NCT01333878 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: Subcutaneous Abatacept

Sponsor

Orrin M Troum, M.D. and Medical Associates

Collaborators

[object Object]